What Do We Know Today About the Outcome of Vasovagal Syncope?

  • R. S. Sheldon
Conference paper


Sudden loss of consciousness is a dramatic and often very frightening event for both patients and their families. While syncope has a wide differential diagnosis, the development of tilt table tests over the past 10 years has shown us that most patients in the community with syncope probably faint because of one of several presentations of vasovagal syncope. A good grasp of the prognosis of the patient is necessary in order to determine whether therapy need be attempted, and whether it is successful. There are a number of variants of vasovagal syncope, and each may have their own prognosis. Before we consider the prognosis of vasovagal syncope, we will first review some of the variants of this disorder and also review our current diagnostic maneuvers.


Tilt Test Tilt Table Vasovagal Syncope Unexplained Syncope Actuarial Risk 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Pongiglione G, Fish FA, Strasburger JF, Benson W (1990) Heart rate and blood pressure response to upright tilt in young patients with unexplained syncope. J Am Coll Cardiol 16: 165–170PubMedCrossRefGoogle Scholar
  2. 2.
    Perry JC, Garson A (1991) The child with recurrent syncope: autonomic function testing and beta-adrenergic hypersensitivity. J Am Coll Cardiol 17: 1168–1171PubMedCrossRefGoogle Scholar
  3. 3.
    Thilenius OG, Quinones JA, Husayni TS, Novak J (1991) Tilt test for diagnosis of unexplained syncope in pediatric patients. Pediatrics 87: 334–338PubMedGoogle Scholar
  4. 4.
    Balaji S, Oslizlok PC, Allen MC, McKay CA, Gillette PC (1994) Neurocardiogenic syncope in children with a normal heart. J Am Coll Cardiol 23: 779–785PubMedCrossRefGoogle Scholar
  5. 5.
    Savage DD, Corwin L, McGee DL, Kannel WB, Wolf PA (1985) Epidemiologic features of isolated syncope: the Framingham study. Stroke 16: 626–629PubMedCrossRefGoogle Scholar
  6. 6.
    Schwartz LS, Goldfischer J, Sprague GJ, Schwartz SP (1969) Syncope and sudden death in aortic stenosis. Am J Cardiol 23: 647–658PubMedCrossRefGoogle Scholar
  7. 7.
    Grech ED, Ramsdale DR (1991) Exertional syncope in aortic stenosis: evidence to support inappropriate left ventricular baroreceptor response. Am Heart J 121: 603–606PubMedCrossRefGoogle Scholar
  8. 8.
    Sheldon R (1994) Tilt table testing in the diagnosis and treatment of syncope. Cardiovasc Rev Rep 8–28Google Scholar
  9. 9.
    Kapoor W, Karpf M, Wieand S, Peterson J, Levey G (1983) A prospective evaluation and follow-up of patients with syncope. N Engl J Med 309: 197–204PubMedCrossRefGoogle Scholar
  10. 10.
    Kushner JA, Kou WH, Kadish AH, Morady F (1989) Natural history of patients with unexplained syncope and a nondiagnostic electrophysiologic study. J Am Coll Cardiol 14: 391–396PubMedCrossRefGoogle Scholar
  11. 11.
    Brignole M, Menozzi C, Gianfranchi L, Bottoni N, Lolli G (1992) The clinical and prognostic significance of the asystolic response during the head-up tilt test. Eur J Cardiac Pacing Electrophysiol 2: 109–113Google Scholar
  12. 12.
    Dhala A, Natale A, Sra J, Deshpande S, Blanck Z, Jazayeri MR, Akhtar M (1995) Relevance of asystole during head-up tilt testing. Am J Cardiol 75: 251–254PubMedCrossRefGoogle Scholar
  13. 13.
    Sheldon R, Killam S (1992) Methodology of isoproterenol-tilt table testing in patients with syncope. J Am Coll Cardiol 19: 773–779PubMedCrossRefGoogle Scholar
  14. 14.
    Brignole M, Menozzi C, Gianfranchi L, Lolli G, Bottoni N, Oddone D (1992) A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol 70: 339–342PubMedCrossRefGoogle Scholar
  15. 15.
    Morillo CA, Leitch JW, Yee R, Klein GJ (1993) A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 22: 1843–1848PubMedCrossRefGoogle Scholar
  16. 16.
    Natale A, Biehl M, Banks B, Maglio C, Krebs A, BudziszewskiGoogle Scholar
  17. M, Koch K, Sra J (1994) Recurrence of neurocardiogenic syncope without therapeutic interventions. Circulation 90: 1–54 (abstr)Google Scholar
  18. 17.
    Morillo CA, Zandri S, Klein GJ, Yee R (1994) Neurally mediated syncope: long-term follow-up of patients with and without pharmacological therapy. Circulation 90: 1–54 (abstr)Google Scholar
  19. 18.
    Sheldon RS, Rose S, Flanagan P, Koshman ML, Killam S (1994) Multivariate predictors of syncope recurrence in drug-free patients following a positive tilt table test. Circulation 90: I55 (abstr)Google Scholar
  20. 19.
    Menozzi C, Brignole M, Lolli G, Bottoni N, Oddone D, Gian-franchi L, Gaggioli G (1993) Follow-up of asystolic episodes in patients with cardioinhibitory, neurally mediated syncope and VVI pacemaker. Am J Cardiol 72: 1152–1155PubMedCrossRefGoogle Scholar
  21. 20.
    Benditt DG, Petersen M, Lurie KG, Grubb BP, Sutton R (1995) Cardiac pacing for prevention of recurrent vasovagal syncope. Ann Intern Med 122: 204–209PubMedGoogle Scholar
  22. 21.
    Almquist A, Goldenberg IF, Milstein S et al. (1989) Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med 320: 346–351PubMedCrossRefGoogle Scholar
  23. 22.
    Strieper MJ, Campbell RM (1993) Efficacy of alpha-adrenergic agonist therapy for prevention of pediatric neurocardiogenic syncope. J Am Coll Cardiol 22: 594–597PubMedCrossRefGoogle Scholar
  24. 23.
    Milstein S, Buetikofer J, Dunnigan A, Benditt DG, Gornick C, Reyes WJ (1990) Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia. Am J Cardiol 65: 1339–1344PubMedCrossRefGoogle Scholar
  25. 24.
    Grubb BP, Samoil D, Kosinski D, Kip K, Brewster P (1994) Use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents. J Am Coll Cardiol 24: 490–494.PubMedCrossRefGoogle Scholar
  26. 25.
    Grubb BP, Temesy-Armos P, Hahn H, Elliott L (1991) Utility of upright tilt-table testing in the evaluation and management of syncope of unknown origin. Am J Med 90: 6–10PubMedCrossRefGoogle Scholar
  27. 26.
    Linzer M, Pontinen M, Gold DT, Divine GW, Felder A, Brooks WB (1991) Impairment of physical and psychosocial function in recurrent syncope. J Clin Epidemiol 44: 10371043Google Scholar
  28. 27.
    Linzer M, Gold DT, Pontinen M, Divine GW, Felder A, Brooks WB (1994) Recurrent syncope as a chronic disease: preliminary validation of a disease-specific measure of functional impairment. J Gen Intern Med 9: 181–186PubMedCrossRefGoogle Scholar
  29. 28.
    Pritchett ELC, Lee KL (1988) Designing clinical trials for paroxysmal atrial tachycardia and other paroxysmal arrhythmias. J Clin Epidemiol 41: 851–858PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia, Milano 1996

Authors and Affiliations

  • R. S. Sheldon
    • 1
    • 2
  1. 1.Cardiovascular Research GroupUniversity of CalgaryCanada
  2. 2.Division of CardiologyCalgary General HospitalCalgaryCanada

Personalised recommendations